Cargando…

m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma

Adenosine N1 methylation (m1A) of RNA, a type of post-transcriptional modification, has been shown to play a significant role in the progression of cancer. The objective of the current research was to analyze the genetic alteration and prognostic significance of m1A regulators in kidney renal clear...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Linjun, Zhou, Weidong, Li, Yuan, Hua, Ruifang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483733/
https://www.ncbi.nlm.nih.gov/pubmed/37679761
http://dx.doi.org/10.1186/s40001-023-01292-3
_version_ 1785102445533200384
author Zhou, Linjun
Zhou, Weidong
Li, Yuan
Hua, Ruifang
author_facet Zhou, Linjun
Zhou, Weidong
Li, Yuan
Hua, Ruifang
author_sort Zhou, Linjun
collection PubMed
description Adenosine N1 methylation (m1A) of RNA, a type of post-transcriptional modification, has been shown to play a significant role in the progression of cancer. The objective of the current research was to analyze the genetic alteration and prognostic significance of m1A regulators in kidney renal clear cell carcinoma (KIRC). Genomic and clinicopathological characteristics were obtained from 558 KIRC patients in the Cancer Genome Atlas (TCGA) and Gene Omnibus Expression (GEO) databases. Alterations in the gene expression of ten m1A-regulators were analyzed and survival analysis was performed using the Cox regression method. We also identified three clusters of patients based on their distinct m1A alteration patterns, using integrated analysis of the ten m1A-related regulators, which were significantly related to overall survival (OS), disease-free survival (DFS) and tumor microenvironment (TME) immune cell infiltration cells in KIRC. Our findings showed that m1A alteration patterns have critical roles in determining TME complexity and its immune cell composition. Furthermore, different m1A expression patterns were significantly associated with DFS and OS rates in KIRC patients. In conclusion, the identified m1A RNA modification patterns offer a potentially effective way to classify KIRC patients based on their TME immune cell infiltration, enabling the development of more personalized and successful treatment strategies for these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-023-01292-3.
format Online
Article
Text
id pubmed-10483733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104837332023-09-08 m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma Zhou, Linjun Zhou, Weidong Li, Yuan Hua, Ruifang Eur J Med Res Research Adenosine N1 methylation (m1A) of RNA, a type of post-transcriptional modification, has been shown to play a significant role in the progression of cancer. The objective of the current research was to analyze the genetic alteration and prognostic significance of m1A regulators in kidney renal clear cell carcinoma (KIRC). Genomic and clinicopathological characteristics were obtained from 558 KIRC patients in the Cancer Genome Atlas (TCGA) and Gene Omnibus Expression (GEO) databases. Alterations in the gene expression of ten m1A-regulators were analyzed and survival analysis was performed using the Cox regression method. We also identified three clusters of patients based on their distinct m1A alteration patterns, using integrated analysis of the ten m1A-related regulators, which were significantly related to overall survival (OS), disease-free survival (DFS) and tumor microenvironment (TME) immune cell infiltration cells in KIRC. Our findings showed that m1A alteration patterns have critical roles in determining TME complexity and its immune cell composition. Furthermore, different m1A expression patterns were significantly associated with DFS and OS rates in KIRC patients. In conclusion, the identified m1A RNA modification patterns offer a potentially effective way to classify KIRC patients based on their TME immune cell infiltration, enabling the development of more personalized and successful treatment strategies for these patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-023-01292-3. BioMed Central 2023-09-07 /pmc/articles/PMC10483733/ /pubmed/37679761 http://dx.doi.org/10.1186/s40001-023-01292-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhou, Linjun
Zhou, Weidong
Li, Yuan
Hua, Ruifang
m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
title m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
title_full m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
title_fullStr m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
title_full_unstemmed m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
title_short m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
title_sort m1a regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483733/
https://www.ncbi.nlm.nih.gov/pubmed/37679761
http://dx.doi.org/10.1186/s40001-023-01292-3
work_keys_str_mv AT zhoulinjun m1aregulatorygenesignaturesareassociatedwithcertainimmunecellcompositionsofthetumormicroenvironmentandpredictsurvivalinkidneyrenalclearcellcarcinoma
AT zhouweidong m1aregulatorygenesignaturesareassociatedwithcertainimmunecellcompositionsofthetumormicroenvironmentandpredictsurvivalinkidneyrenalclearcellcarcinoma
AT liyuan m1aregulatorygenesignaturesareassociatedwithcertainimmunecellcompositionsofthetumormicroenvironmentandpredictsurvivalinkidneyrenalclearcellcarcinoma
AT huaruifang m1aregulatorygenesignaturesareassociatedwithcertainimmunecellcompositionsofthetumormicroenvironmentandpredictsurvivalinkidneyrenalclearcellcarcinoma